IRLAB Therapeutics AB (publ) (IRLAB-A) — Net Asset Quality Index
IRLAB Therapeutics AB (publ) (IRLAB-A) has a Net Asset Quality Index of 22.2% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr138.21 Million minus total liabilities of Skr107.49 Million yields net assets of Skr30.72 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check asset resilience ratio of IRLAB Therapeutics AB (publ) to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
IRLAB Therapeutics AB (publ) Net Asset Quality Index Over Time (2013–2025)
This chart shows how IRLAB Therapeutics AB (publ)'s Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of December 2025, the index stands at 22.2%, representing net assets of Skr30.72 Million against total assets of Skr138.21 Million SEK. See working capital to net assets of IRLAB Therapeutics AB (publ) to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for IRLAB Therapeutics AB (publ) (2013–2025)
The table below presents the year-by-year Net Asset Quality Index for IRLAB Therapeutics AB (publ) from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see IRLAB Therapeutics AB (publ) stock valuation.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 22.2% | Skr30.72 Million | Skr138.21 Million | Skr107.49 Million | ▼ -1.7 pp |
| 2024 | 24.0% | Skr32.63 Million | Skr136.21 Million | Skr103.58 Million | ▼ -41.4 pp |
| 2023 | 65.4% | Skr115.76 Million | Skr177.12 Million | Skr61.36 Million | ▼ -24.5 pp |
| 2022 | 89.9% | Skr290.83 Million | Skr323.56 Million | Skr32.72 Million | ▲ +5.3 pp |
| 2021 | 84.6% | Skr399.48 Million | Skr472.45 Million | Skr72.97 Million | ▼ -9.4 pp |
| 2020 | 94.0% | Skr347.88 Million | Skr370.07 Million | Skr22.19 Million | ▲ +6.6 pp |
| 2019 | 87.4% | Skr181.83 Million | Skr208.07 Million | Skr26.24 Million | ▼ -7.1 pp |
| 2018 | 94.5% | Skr212.48 Million | Skr224.94 Million | Skr12.46 Million | ▼ -0.6 pp |
| 2017 | 95.1% | Skr155.00 Million | Skr162.97 Million | Skr7.97 Million | ▲ +3.3 pp |
| 2016 | 91.8% | Skr103.89 Million | Skr113.11 Million | Skr9.22 Million | ▲ +0.8 pp |
| 2015 | 91.0% | Skr92.03 Million | Skr101.09 Million | Skr9.06 Million | ▲ +7.8 pp |
| 2014 | 83.2% | Skr88.57 Million | Skr106.43 Million | Skr17.86 Million | ▼ -16.7 pp |
| 2013 | 100.0% | Skr24.99 Million | Skr25.00 Million | Skr7.00K | — |